I was hoping for today! Now that the $2 level question keeps being raised I am not sure. I thought Joe was confident we had all our ducks in a row and the audited annual report would confirm such. It would seem to me, if the annual report clearly indicates we are good the market should reward the PPS. Not just because it clears the NAZ criteria but it shows tremendous improvement in GNBT's business YOY.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links